Recordati

Recordati

France - Saint-Victor
Biotechnology
WebsiteLinkedInCareers Page

Focus: Small Molecule Manufacturing

Recordati is a life sciences company focused on Small Molecule Manufacturing.

OncologyEndocrinologyRare DiseasesCardiovascularHematology
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0

Products & Portfolio (10)

4 discontinued products not shown

CARBAGLU
carglumic acid
LOE Approaching
ORAL · TABLET, FOR SUSPENSION
Carbamoyl Phosphate Synthetase 1 Activators
2010
30
CHEMET
succimer
LOE Approaching
ORAL · CAPSULE
Lead Chelating Activity
lead poisoning in pediatric patients aged 1 yearolder with blood lead levels above 45 mcg/dLlead poisoning in a lead-containing environment+1 more
1991
30
CYSTADANE
betaine
LOE Approaching
ORAL · FOR SOLUTION
Methylating Activity
1996
30
CYSTADROPS
cysteamine hydrochloride
Peak
OPHTHALMIC · SOLUTION/DROPS
cystine-depleting agent by converting cystine to cysteine and cysteine-cysteamine mixed disulfides and reduces corneal cystine crystal accumulation.
corneal cystine crystal deposits in adultschildren with cystinosis
2020
30
ENJAYMO
sutimlimab-jome
Peak
INJECTION · INJECTABLE
Classical Complement Pathway Inhibitors
hemolysis in adults with cold agglutinin disease (CAD)
2022
30
ISTURISA
osilodrostat
Peak
SMORAL · TABLET
inhibitor. It inhibits 11beta-hydroxylase (CYP11B1), the enzyme responsible for the final step of cortisol biosynthesis in the adrenal gland. In a Chinese hamster lung cell line V79-4 that overexpresses human CYP11B1, adrenodoxin and adrenodoxin reductase, osilodrostat inhibited the activity of human CYP11B1 dose-dependently with IC50 values of 2.5 ± 0.1 nM (n = 4).
endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option
2020
0
NEOPROFEN
ibuprofen lysine
Peak
INTRAVENOUS · INJECTABLE
(PDA) in neonates is not known. In adults, ibuprofen is an inhibitor of prostaglandin synthesis.
2006
0
SIGNIFOR
pasireotide
LOE Approaching
PeptideSUBCUTANEOUS · SOLUTION
Somatostatin Receptor Agonists
2012
25
SIGNIFOR LAR KIT
pasireotide
LOE Approaching
PeptideINTRAMUSCULAR · FOR SUSPENSION
2014
15
SYLVANT
siltuximab
Peak
mAbINJECTION · INJECTABLE
Interleukin-6 Antagonists
2014
30

Pipeline & Clinical Trials

Colombia National Porphyria Registry
Rare Diseases
N/A
Clinical Trials (1)
NCT05496933Colombia National Porphyria Registry
N/A
The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients
Mycosis Fungoides
N/A
Clinical Trials (1)
NCT06421571The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients
N/A
intradermal pholcodine allergy test in cases
Neuromuscular Blocking Agents Anaphylaxis
N/A
Various labs and imaging tests
Mild Autonomous Cortisol Secretion (MACS)
N/A
Clinical Trials (1)
NCT06344143Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma
N/A
Data-collection
Neuroblastoma
N/A
Clinical Trials (1)
NCT04253015A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta
N/A
Leuprolide Acetate
Prostate Cancer
N/A
Clinical Trials (1)
NCT03990194Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer
N/A
Colonization with Group B Streptococcus During Pregnancy
Gestational Mother
N/A
Clinical Trials (1)
NCT03671486Colonization with Group B Streptococcus During Pregnancy
N/A
Cross-sectional, Non-randomized Observational Study to Assess the Frequency of Reduced Sodium Intake
Dietary Deficiency
N/A
Clinical Trials (1)
NCT06121583Cross-sectional, Non-randomized Observational Study to Assess the Frequency of Reduced Sodium Intake in the Primary Care Setting - LAXAP
N/A
N/A
Clinical Trials (1)
NCT04176523Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach
N/A
Lactobacillus salivarius V4II-90
Gestational Mother
N/A
Clinical Trials (1)
NCT03669094Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women
N/A
N/A
Clinical Trials (1)
NCT05382156Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
N/A
Carglumic Acid
Hyperammonemia
N/A
Clinical Trials (1)
NCT05040178An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
N/A
Lactobacillus salivarius PS7 during 6 months
Acute Otitis Media
N/A
Clinical Trials (1)
NCT03614117Effect of a New Probiotic Strain on Recurrent Acute Otitis Media in Children (PROMAR)
N/A
Methadone
Cancer Pain
N/A
Clinical Trials (1)
NCT05265442Real-life Observational Study of Cancer Pain Management With Methadone
N/A
N/A
Clinical Trials (1)
NCT05995834Producing a Novel Symptom Burden Scale for People Living With Idiopathic Multicentric Castleman Disease (ISBUS)
N/A
Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH
Benign Prostatic Hyperplasia
N/A
Clinical Trials (1)
NCT03179670Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH
N/A
N/A
Clinical Trials (1)
NCT05791708Cold Agglutinin Disease Real World Evidence Registry
N/A
N/A
Clinical Trials (1)
NCT02839824Evaluation of the Quality of Bowel Cleansing in a Real Clinical Practice Setting
N/A
Chlormethine
Mycosis Fungoides
N/A
Clinical Trials (1)
NCT05303480Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides
N/A
Pasireotide
Cushings Disease
N/A
Clinical Trials (1)
NCT02310269Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
N/A
N/A
Clinical Trials (1)
NCT06430528A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
N/A
Osilodrostat
Cushing's Syndrome
N/A
Clinical Trials (1)
NCT05633953Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome
N/A
Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
Cutaneous T-Cell Lymphoma/Mycosis Fungoides
N/A
Clinical Trials (1)
NCT07046663Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
N/A
Phase 1
Clinical Trials (1)
NCT06447376Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
Phase 1
Pasireotide cartridge with reusable ServoPen
Pharmacokinetics
Phase 1
Clinical Trials (1)
NCT07312643Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single Subcutaneous Dose Administration Using a Reusable ServoPen With Cartridge as Compared to Administration Using a Syringe Drawn From an Ampule
Phase 1
Rec 0/0438 1 mg or Rec 0/0438 2 mg
Neurogenic Detrusor Overactivity
Phase 1/2
Clinical Trials (1)
NCT03482037Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury
Phase 1/2
Pasireotide Long Acting Release
Neuroendocrine Tumors
Phase 2
Clinical Trials (1)
NCT01253161Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
Phase 2
Phase 2
Clinical Trials (1)
NCT04838860Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease
Phase 2
Phase 2
Clinical Trials (1)
NCT04276558REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients
Phase 2
Dinutuximab Beta, Zoledronic acid, Interleukin-2
Leiomyosarcoma
Phase 2
Clinical Trials (1)
NCT05080790Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma
Phase 2
Siltuximab
Schwannomatosis
Phase 2
Clinical Trials (1)
NCT05684692Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
Phase 2
Phase 2
Clinical Trials (1)
NCT01206582A Pilot Study of Hemin Therapy for Gastroparesis (Diabetes Mellitus)
Phase 2
Phase 2
Clinical Trials (1)
NCT06679829A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Phase 2
Phase 2
Clinical Trials (1)
NCT07104812Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
Phase 2
Phase 2
Clinical Trials (1)
NCT03708900Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
Phase 2
Phase 2
Clinical Trials (1)
NCT01093807Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension
Phase 2
osilodrostat
Cushing's Syndrome
Phase 2
Clinical Trials (1)
NCT03606408Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699
Phase 2
Pasireotide Diaspartate
Post-Bariatric Hypoglycemia
Phase 2
Clinical Trials (1)
NCT05928390Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia
Phase 2
Phase 2
Clinical Trials (1)
NCT06295952A Study of Pasireotide in People With Prolactinoma
Phase 2
Phase 3
Clinical Trials (1)
NCT04616586SILtuximab in Viral ARds (SILVAR) Study
Phase 3
Phase 3
Clinical Trials (1)
NCT00359905Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH
Phase 3
Phase 3
Clinical Trials (1)
NCT01793480Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.
Phase 3
Mercaptamine
Cystinosis
Phase 3
Clinical Trials (1)
NCT04125927Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)
Phase 3
Phase 3
Clinical Trials (1)
NCT02003742Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH
Phase 3
Osilodrostat
Hypertension
Phase 4
Clinical Trials (1)
NCT07247162Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Phase 4
Phase 4
Clinical Trials (1)
NCT01794793Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
Phase 4
Phase 4
Clinical Trials (1)
NCT01757769Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Phase 4
Phase 4
Clinical Trials (1)
NCT04297423Two Low Volume Regimens for Colorectal Cancer Screening Colonoscopy
Phase 4
Phase 4
Clinical Trials (1)
NCT07247058Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)
Phase 4
Intervention/Treatment
Endogenous Cushing Syndrome
Phase 4
Clinical Trials (1)
NCT06131580Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome
Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 14 approved products, 49 clinical trials
Top TAs: Oncology, Endocrinology, Rare Diseases
Publications: 25 in PubMed
Portfolio Health
Peak5 (36%)
LOE Approaching9 (64%)
14 total products
Therapeutic Area Focus
Oncology
2 marketed12 pipeline
Endocrinology
3 marketed9 pipeline
Rare Diseases
1 marketed1 pipeline
Cardiovascular
2 pipeline
Hematology
1 marketed
Immunology
1 marketed
Ophthalmology
1 marketed
Marketed
Pipeline